Intron-A from Fulford
[Interferon Alfa-2B ]
Strength
Intron-A 3 MIU
Volume
1
Presentation
Intron-A PEN
Price*
N/A
Strength
Intron-A 5 MIU
Volume
1
Presentation
Intron-A PEN
Price*
N/A
Strength
Intron-A 18 MIU x 1.2mL
Volume
1
Presentation
Intron-A PEN
Price*
13698.00
Strength
Intron-A 30 MIU x 1.2mL
Volume
1
Presentation
Intron-A PEN
Price*
22830.00
Intron-A from Fulford contains Interferon Alfa-2B
Below are some of the details of Interferon Alfa-2B (generic)
Interferon ALPHA-2B is an antiviral drug originally discovered in the laboratory of Charles Weissmann at the University of Zurich, developed at Biogen, and ultimately marketed by Schering-Plough under the tradename Intron-A. It has been used for a wide range of indications, including viral infections and cancers.
This drug is approved around the world for the treatment of chronic hepatitis C, chronic hepatitis B, hairy cell leukemia, chronic myelogenous leukemia, multiple myeloma, follicular lymphoma, carcinoid tumor, and malignant melanoma.
FOLLOW US:
Thank
You!
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.